Paul Cadman

Paul Cadman

Columnist
CEO of the One Thousand Trades Group, Paul is an internationally recognised business leader and knowledge broker with expertise in tech, manufacturing, retail and consultancy.
Politics Tech

Sunak joins Silicon Valley elite

Ex Prime Minister takes advisory roles with Microsoft and Anthropic Former UK prime minister Rishi Sunak has been appointed as a senior adviser

Read More
Sport

New boss of football regulator

Richard Monks to lead new watchdog The newly formed Independent Football Regulator (IFR) has appointed Richard Monks as its first Chief Executive Officer,

Read More
Tech Viewpoint

How we must harness AI

What remains when the machines take the work? Imagine a world where your benefit to others is the measure of success, not the

Read More
Culture Viewpoint

Prince Andrew: No return

The final fall: Met police probe, royal exile, and a legacy in ruins The walls have closed in. Prince Andrew, once the Duke

Read More
Defence Politics

UK delivers missiles early

Trade mission boosts Kyiv defence ties Hundreds of British-made air defence missiles have been delivered to Ukraine five months ahead of schedule, as

Read More
Business News Finance World Affairs

Wall Street rebounds strongly

Dealmaking revival lifts investment banking revenues above $9bn Wall Street’s biggest banks are set to report their strongest investment banking quarter in nearly

Read More
Defence

Royal Navy Wildcats armed up

Sea Venom missile reaches frontline readiness The Royal Navy has taken a major leap in firepower with its Wildcat maritime attack helicopters now

Read More
Defence

Navy engineers take pit-lane lessons

Sailors visit Williams F1 to learn from racing innovators A team of Royal Navy engineers swapped ships for supercars as they spent a

Read More
Defence People World Affairs

Royal Marines halt £35m haul

Snipers disable drugs boat in Gulf of Oman Royal Marine snipers aboard a Wildcat helicopter have stopped a speeding drugs boat in the

Read More
Birmingham Life Sciences

Just another astonishing day

‘Neurosurgery, clinical trials, combating cancer – things I saw on a life sciences tour of Birmingham‘ When a small group of invited guests

Read More